Translate this article.

I'm Steve Ember, and this is the VOA Special English Health Report. Sometimes, the best medicine is more than a good medicine. For example, malaria, tuberculosis and AIDS can all be treated with drugs. Miles? Squibb and Gilead combine many H.I.V drugs into one pill, but this may mean taking many pills. It would be easier if the pharmaceutical company mixed all the drugs into one tablet and took it once a day. Now, two companies claim that they have created the H.I.V virus that was initially treated as causing AIDS. Is the company Bristol-Myers Squibb? Squibb and Gilead Technology. They have developed a unique tablet, which combines three drugs currently on the market. Bristol Miles? Squibb sells one of them under the name of Susti tile. In 20400, Gilead mixed other drugs Emtriva and Viread into a pill. Combined drug intervention is not only a technical problem. If the drug is produced by different companies, it will also interfere with competition. The result of this new once-a-day pill is described because of its first joint venture agreement in AIDS treatment. In June+10, 5438, the New England Journal of Medicine published a study on new tablets. The researchers compared its efficiency with the widely used combination of Sustiva and Combivir. Combivir contains two drugs, AZT and 3TC. The researchers said that after a year of treatment, the new tablets were suppressed at the level of H.I.V, followed by more patients and fewer side effects. Gilead paid for Professor Joel Gallant's research at Johns? Hopkins Medical School in Baltimore, Maryland, led the study. He is a paid consultant for Gilead and Bristol MeyersSquibb and Combivir, a manufacturer of GlaxoSmithKline. GlaxoSmithKline responded to the results of the study, saying that the only study was the limit value. It believes that the efficiency of Combivir has been demonstrated in more than 50 studies. Once the daily pills are not announced, the price is new. But what about Gilead and Bristol Myers? Squibb said that they would provide this product to developing countries at a lower price. They plan to apply to the US Food and Drug Administration for approval of new drugs in the coming months. Because it contains different drugs, there is a limit to who can take it. For example, pregnant women are told not to take Sustiva because of the risk of birth disorders. Experts say that more than 40 million people in the world are infected with HIV? Kirk wrote, Read and listen to our report in www.unsv.com. I'm Steve Ember.